Showing results (111-120 of 383) with videos related to
Sort By:
Pageof 39
Seminars in Oncology|August 1, 1997
Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trialsR F DeVore, M Jagasia, D H JohnsonThe Journal of Burn Care & Rehabilitation|October 6, 1997
The effects of U-74389G, a 21-aminosteroid, on pulmonary vascular resistance after a scaldD H Johnson, T S Hurst, I MayersHuman Heredity|January 1, 1997
Three mutations in the paired homeodomain of PAX3 that cause Waardenburg syndrome type 1R Morell, M L Carey, A K Lalwani, et al.Genomics|June 15, 1996
Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variationJ H Asher, R W Harrison, R Morell, et al.Cancer Treatment Reviews|March 1, 1991
A comparison of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin (H-CAP) vs. cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced ovarian cancerF A Greco, D H Johnson, J D HainsworthArchives of Ophthalmology (Chicago, Ill. : 1960)|December 1, 1982
The ultrastructure of Descemet's membrane. II. Aphakic bullous keratopathyD H Johnson, W M Bourne, R J CampbellSeminars in Oncology|December 1, 1992
Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary siteF A Greco, D H Johnson, J D HainsworthMilitary Medicine|May 1, 1993
A case study of a coordinated care program: development and implementation of Fort Sill's Catchment Area Management ProjectA G Santos, D H Johnson, R P HudakGrowth|September 1, 1975
Fitting Richards' Curve to data of diverse originsD H Johnson, A B Sargeant, S H AllenSeminars in Oncology|April 1, 1992
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary siteJ D Hainsworth, D H Johnson, F A GrecoPageof 39